Implantable Cardioverter Defibrillator Multisensor Monitoring during Home Confinement Caused by the COVID-19 Pandemic
Matteo Ziacchi,
Leonardo Calò,
Antonio D’Onofrio,
Michele Manzo,
Antonio Dello Russo,
Luca Santini,
Giovanna Giubilato,
Cosimo Carriere,
Vincenzo Ezio Santobuono,
Gianluca Savarese,
Carmelo La Greca,
Giuseppe Arena,
Antonello Talarico,
Ennio Pisanò,
Massimo Giammaria,
Antonio Pangallo,
Monica Campari,
Sergio Valsecchi,
Igor Diemberger
Affiliations
Matteo Ziacchi
Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Policlinico S.Orsola-Malpighi, 40138 Bologna, Italy
Leonardo Calò
Policlinico Casilino, 00118 Rome, Italy
Antonio D’Onofrio
“Unità Operativa di Elettrofisiologia, Studio e Terapia delle Aritmie”, Monaldi Hospital, 80131 Naples, Italy
Michele Manzo
OO.RR. San Giovanni di Dio Ruggi d’Aragona, 84125 Salerno, Italy
Antonio Dello Russo
Clinica di Cardiologia e Aritmologia, Università Politecnica delle Marche, “Ospedali Riuniti”, 60126 Ancona, Italy
Azienda Ospedaliera Universitaria Ospedali Riuniti di Trieste—Cattinara, 34149 Trieste, Italy
Vincenzo Ezio Santobuono
Policlinico di Bari, University of Bari, 70126 Bari, Italy
Gianluca Savarese
S. Giovanni Battista Hospital, 06034 Foligno, Italy
Carmelo La Greca
Fondazione Poliambulanza, 25124 Brescia, Italy
Giuseppe Arena
Ospedale Civile Apuane, 54100 Massa, Italy
Antonello Talarico
SS. Annunziata Hospital, 87100 Cosenza, Italy
Ennio Pisanò
Vito Fazzi Hospital, 73100 Lecce, Italy
Massimo Giammaria
Division of Cardiology, Maria Vittoria Hospital, 10144 Turin, Italy
Antonio Pangallo
Grande Ospedale Metropolitano “Bianchi-Melacrino”, 89124 Reggio Calabria, Italy
Monica Campari
Boston Scientific Italia, 20134 Milan, Italy
Sergio Valsecchi
Boston Scientific Italia, 20134 Milan, Italy
Igor Diemberger
Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Policlinico S.Orsola-Malpighi, 40138 Bologna, Italy
Aims: The utilization of remote monitoring platforms was recommended amidst the COVID-19 pandemic. The HeartLogic index combines multiple implantable cardioverter defibrillator (ICD) sensors and has proved to be a predictor of impending heart failure (HF) decompensation. We examined how multiple ICD sensors behave in the periods of anticipated restrictions pertaining to physical activity. Methods: The HeartLogic feature was active in 349 ICD and cardiac resynchronization therapy ICD patients at 20 Italian centers. The period from 1 January to 19 July 2020, was divided into three phases: pre-lockdown (weeks 1–11), lockdown (weeks 12–20), post-lockdown (weeks 21–29). Results: Immediately after the implementation of stay-at-home orders (week 12), we observed a significant drop in median activity level whereas there was no difference in the other contributing parameters. The median composite HeartLogic index increased at the end of the Lockdown. The weekly rate of alerts was significantly higher during the lockdown (1.56 alerts/week/100 pts, 95%CI: 1.15–2.06; IRR = 1.71, p = 0.014) and post-lockdown (1.37 alerts/week/100 pts, 95%CI: 0.99–1.84; IRR = 1.50, p = 0.072) than that reported in pre-lockdown (0.91 alerts/week/100 pts, 95%CI: 0.64–1.27). However, the median duration of alert state and the maximum index value did not change among phases, as well as the proportion of alerts followed by clinical actions at the centers and the proportion of alerts fully managed remotely. Conclusions: During the lockdown, the system detected a significant drop in the median activity level and generated a higher rate of alerts suggestive of worsening of the HF status.